Enhanced bioavailability of azathioprine compared to 6‐mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy
Open Access
- 1 August 2000
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (8) , 1009-1014
- https://doi.org/10.1046/j.1365-2036.2000.00812.x
Abstract
Background: Azathioprine and 6‐mercaptopurine have proven efficacy in the treatment of Crohn’s disease. Immunosuppression is mediated by their intracellular metabolism into active 6‐thioguanine meta...Keywords
This publication has 20 references indexed in Scilit:
- Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's diseaseGastroenterology, 1999
- 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.Gut, 1996
- Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.Gut, 1996
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyNew England Journal of Medicine, 1994
- G-CSF or GM-CSF to Ameliorate Chemotherapy-induced CytopeniaJournal of Pediatric Hematology/Oncology, 1993
- Studies Strategies and DesignJournal of Pediatric Hematology/Oncology, 1993
- Concurrent unilateral chromatid damage and DNA strand breakage in response to 6-thioguanine treatmentBiochemical Pharmacology, 1986
- Variable Bioavailability of Oral MercaptopurineNew England Journal of Medicine, 1983
- Clinical Pharmacokinetics of AnticonvulsantsClinical Pharmacokinetics, 1976
- Clinical Pharmacology and Therapeutic Use of Digitalis Glycosides1Drugs, 1973